Vellum Health is an Austin, Texas mobile healthcare company that delivers advanced intravenous (IV) care at the bedside. It combines on-demand vascular access, infusion therapy, and on-site blood transfusions with trained clinicians and an AI-powered patient intelligence platform. By extending hospital-grade IV services into skilled nursing facilities, long-term acute care centers, and homes, Vellum helps hospitals, payors, and post-acute providers avoid unnecessary hospitalizations, speed time-to-treatment, and lower the cost of care.
Tyler Payne is the founder and CEO of Vellum Health, an Austin-based company that sends clinicians to draw a line, hang an infusion, or run a blood transfusion at a patient's bedside in a skilled nursing facility or living room instead of an emergency room. He rolled up a set of regional vascular-access businesses, wrapped them in a single brand and an AI platform that reads a facility's EMR to find patients who need care, and closed a Series A in mid-2025 led by FCA Venture Partners. Before Vellum he helped build CVS Health's nationwide clinical-trial infrastructure and worked at Elligo Health Research and ePatientFinder. He holds a molecular biology degree from Colorado and an MBA from UT Austin's McCombs School.